BROWSE·page 133 of 311

Browse EX-10 agreements

3,723 matching material contract exhibits.


EX-10.2

Blue Owl Digital Infrastructure Trust

Document

Exhibit 10.2

EXECUTION VERSION

                                                                                                                                                                                          

CERTAIN INFORMATION MARKED AS [***] HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO REGULATION S-K, BECAUSE IT IS NOT MATERIAL AND/OR THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

LOAN AGREEMENT

Dated as of June 23, 2026

Among

GCDC PURCHASER PHASE 1 LLC, as Borrower,

and

JPMORGAN CHASE BANK, NATIONAL ASSOCIATION and

GOLDMAN SACHS BANK USA,

collectively, as Lender

v.


TABLE OF CONTENTS

Page

ARTICLE I

DEFINITIONS; PRINCIPLES OF CONSTRUCTION

1

Section 1.1.

Definitions

1

Section 1.2.

Principles of Construction

52

ARTICLE II

GENERAL TERMS

53

Section 2.1.

Loan Commitment; Disbursement to Borrower.

53

2.1.1.

Agreement to Lend and Borrow

53

2.1.2.

No Reborrowings

53

2.1.3.

Intentionally Omitted.

53

2.1.4.

The Note, Mortgage and Loan Documents

53

2.1.5.

Use of Proceeds

53

2.1.6.

EX-10.2·8-K·CIK 2069692·ACC 0002069692-26-000042·Filed Jun 29, 2026, 17:23 ET

MASTER SERVICES AGREEMENT

 

This Master Services Agreement (this “Agreement”) is entered into as of August 21, 2024 (the “Effective Date”), by and between Lohman & Associates, Inc., a California corporation (“L&A”), and Cadrenal Therapeutics, Inc., a Delaware corporation (“Client”).

  

WHEREAS, L&A provides accounting, business strategy and consulting, and fractional chief financial officer services;

 

WHEREAS, Client requires one or more of such services in connection with Client’s business; and

 

WHEREAS, Client wishes to engage, and L&A desires to accept an engagement pursuant to this Agreement as more specifically set forth in any Statement of Work (“SOW”) to perform the services set forth therein.

 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. SERVICES

EX-10.1·8-K·CIK 1937993·ACC 0001213900-26-073213·Filed Jun 29, 2026, 17:19 ET

SCOPE OF WORK NUMBER FIVE

FINANCE AND ACCOUNTING CONSULTING SERVICES

1. SERVICES DESCRIPTION AND SPECIFICATIONS

L&A will provide accounting and finance consulting services as requested by Cadrenal Therapeutics, Inc. (the “Client”). Services will be performed by John Sharp (the “Consultant”) as an independent contractor. Consultant shall serve as the Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Client. The following describes the scope of Consultant’s engagement:

 

Onboarding

 

a)

Obtain access to all financial systems, records, and data repositories;

 

b)

Review existing financial and operational materials, including financial statements, forecasts, material agreements, and Board reporting packages; and

 

c)

Meet with management and the existing accounting provider to align on reporting requirements, growth objectives, and priority initiatives; and

 

 

 

d)

Meet with and train with internal company finance team members, as needed.

EX-10.2·8-K·CIK 1937993·ACC 0001213900-26-073213·Filed Jun 29, 2026, 17:19 ET

EX-10.1

Oncotelic Therapeutics, Inc.

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 23, 2026, by and between ONCOTELIC THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 29397 Agoura Road Suite 107, Agoura Hills, CA 91301 (the “Company”), and PACIFIC PIER CAPITAL II, LP, a Delaware limited partnership, with its address at 285 East Imperial Highway, Suite 203, Fullerton, CA 92835 (the “Buyer”).

 

WHEREAS:

 

A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506(b) promulgated by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act;

EX-10.1·8-K·CIK 908259·ACC 0001493152-26-031124·Filed Jun 29, 2026, 17:15 ET

EX-10.2

Oncotelic Therapeutics, Inc.

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE PURCHASE AGREEMENT)), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S UNDER SAID ACT OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

Principal Amount: $178,410.00

Issue Date: June 23, 2026

Actual Amount of Purchase Price: $157,000.80

 

PROMISSORY NOTE

EX-10.2·8-K·CIK 908259·ACC 0001493152-26-031124·Filed Jun 29, 2026, 17:15 ET

EX-10.1

Andersen Group Inc.

CREDIT AGREEMENT

dated as of

June 25, 2026

among

ANDERSEN TAX LLC

the Lenders party hereto, and

JPMORGAN CHASE BANK, N.A.,

as Administrative Agent

JPMORGAN CHASE BANK, N.A.,

as Sole Bookrunner and Sole Lead Arranger

ASSET BASED LENDING

 

 

 


TABLE OF CONTENTS

 

 

 

 

  

Page

 

SECTION 1.01

 

Defined Terms

  

 

1

 

SECTION 1.02

 

Classification of Loans and Borrowings

  

 

45

 

SECTION 1.03

 

Terms Generally

  

 

45

 

SECTION 1.04

 

Accounting Terms; GAAP

  

 

45

 

SECTION 1.05

 

Interest Rates; Benchmark Notifications

  

 

46

 

SECTION 1.06

 

[Reserved.]

  

 

46

 

SECTION 1.07

 

Status of Obligations

  

 

46

 

SECTION 1.08

 

Letters of Credit

  

 

47

 

SECTION 1.09

 

Divisions

  

 

47

 

ARTICLE II THE CREDITS

  

 

47

 

SECTION 2.01

 

Commitment

  

 

47

 

SECTION 2.02

 

Loans and Borrowings

  

 

47

 

SECTION 2.03

 

Borrowing Procedures; Requests for Revolving Borrowings

  

 

48

 

SECTION 2.04

 

Protective Advances

  

 

49

 

SECTION 2.05

EX-10.1·8-K·CIK 2065708·ACC 0001193125-26-288725·Filed Jun 29, 2026, 17:13 ET

EX-10.3

Andersen Group Inc.

PLEDGE AND SECURITY AGREEMENT

THIS PLEDGE AND SECURITY AGREEMENT (as it may be amended, restated, supplemented or otherwise modified from time to time, the “Security Agreement”) is entered into as of June 25, 2026 by and among Andersen Tax LLC, a Delaware limited liability company (“Borrower”), Andersen Tax Holdings LLC, a Delaware limited liability company (“Holdings”), Andersen Group Inc., a Delaware corporation (“AGI”), AT Umbrella LLC, a Delaware limited liability company (“ATU”), Andersen Global Mobility LLC, a Delaware limited liability company (“Mobility”), and any additional entities which become parties to this Security Agreement by executing a Security Agreement Supplement hereto in substantially the form of Annex I hereto (such additional entities, together with Borrower, Holdings, AGI, ATU, and Mobility each a “Grantor”, and collectively, the “Grantors”), and JPMorgan Chase Bank, N.A., in its capacity as administrative agent (together with its successors and assigns, the “Administrative Agent”) for the lenders party to the Credit Agreement referred to below.

EX-10.3·8-K·CIK 2065708·ACC 0001193125-26-288725·Filed Jun 29, 2026, 17:13 ET

EX-10.2

Andersen Group Inc.

SUBORDINATION AGREEMENT

THIS SUBORDINATION AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”) is entered into as of June 25, 2026, by and among AT UMBRELLA LLC, a Delaware limited liability company (the “Company”), the other Loan Parties (as defined below) party hereto, ANDERSEN AGGREGATOR LLC, a Delaware limited liability company (“Subordinated Creditor”) and JPMorgan Chase Bank, N.A., in its capacity as administrative agent for the Senior Secured Parties defined below (“Agent”).

R E C I T A L S

EX-10.2·8-K·CIK 2065708·ACC 0001193125-26-288725·Filed Jun 29, 2026, 17:13 ET

EXHIBIT 10.1

FS KKR Capital Corp

Execution Version

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 29, 2026, is entered into by and between FS KKR Capital Corp., a Maryland corporation (including its successors, the “Corporation”), and KKR Alternative Assets L.P., a Delaware limited partnership (the “Holder”).

 

ARTICLE I DEFINITIONS

 

Section 1.1           Definitions. The following terms shall have the meanings set forth in this Section 1.1:

 

Closing” shall have the meaning ascribed to such term in the Purchase Agreement.

 

Common Stock” means the Corporation’s common stock, par value $0.001 per share.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, or any similar federal statute, and the rules and regulations promulgated by the SEC thereunder.

EX-10.1·8-K·CIK 1422183·ACC 0001104659-26-078916·Filed Jun 29, 2026, 17:06 ET

EX-10.1

AMERICAN EAGLE OUTFITTERS INC

AMERICAN EAGLE OUTFITTERS, INC.

AMENDED AND RESTATED

2023 STOCK AWARD AND INCENTIVE PLAN

Effective as of the Restated Effective Date (as defined below), the American Eagle Outfitters, Inc. 2023 Stock Award and Incentive Plan (as amended from time to time, the “Plan”) is hereby amended and restated as set forth below. The Plan was originally effective as of the Original Effective Date (as defined below). The Plan as amended and restated herein shall apply to all Awards (as defined below) granted under the Plan on or after the Restated Effective Date. Awards granted under the Plan prior to the Restated Effective Date shall continue to be governed by the terms of the Plan prior to amendment and restatement.

EX-10.1·8-K·CIK 919012·ACC 0001193125-26-288667·Filed Jun 29, 2026, 17:00 ET

Execution Version


SECOND AMENDED AND RESTATED

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

VERIZON MASTER TRUST, as Trust

CELLCO PARTNERSHIP d/b/a VERIZON WIRELESS, as Servicer

and

PENTALPHA SURVEILLANCE LLC, as Asset Representations Reviewer

Dated as of April 23, 2024

 



TABLE OF CONTENTS

Page

 

ARTICLE I

USAGE AND DEFINITIONS

1

 

 

 

Section 1.1

Usage and Definitions

1

Section 1.2

Additional Definitions

1

Section 1.3

Review Materials and Test Definitions

2

 

 

 

ARTICLE II

ENGAGEMENT OF ASSET REPRESENTATIONS REVIEWER

3

 

 

 

Section 2.1

Engagement; Acceptance

3

Section 2.2

Confirmation of Status

3

 

 

 

ARTICLE III

ASSET REPRESENTATIONS REVIEW PROCESS

3

 

 

 

Section 3.1

Review Notices and Schedule of Tests

3

Section 3.2

Identification of Group Review Receivables

3

Section 3.3

Review Materials

4

Section 3.4

Performance of Reviews

4

Section 3.5

Review Reports

5

Section 3.6

Review Representatives

5

Section 3.7

Dispute Resolution

6

Section 3.8

Limitations on Review Obligations

6

EX-10.9·8-K·CIK 1844964·ACC 0000929638-26-002382·Filed Jun 29, 2026, 16:47 ET

FORM OF

SERIES 2026-2 ACCOUNT CONTROL AGREEMENT

 

among

 

VERIZON MASTER TRUST, as Grantor

 

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Secured Party

 

and

 

U.S. BANK NATIONAL ASSOCIATION, as Financial Institution

 

Dated as of June 30, 2026

 

 



TABLE OF CONTENTS

Page

 

ARTICLE I USAGE AND DEFINITIONS

1

Section 1.1

Usage and Definitions

1

 

 

 

ARTICLE II ESTABLISHMENT OF COLLATERAL ACCOUNTS

1

Section 2.1

Description of Accounts

1

Section 2.2

Account Changes

2

Section 2.3

Account Types

2

Section 2.4

Securities Accounts

2

Section 2.5

“Financial Assets” Election

3

 

 

 

ARTICLE III SECURED PARTY CONTROL

3

Section 3.1

Control of Collateral Accounts

3

Section 3.2

Investment Instructions

3

Section 3.3

Conflicting Orders or Instructions

3

 

 

 

ARTICLE IV SUBORDINATION OF LIEN; WAIVER OF SET-OFF

4

Section 4.1

Subordination of Lien; Waiver of Set-Off

4

 

 

 

ARTICLE V REPRESENTATIONS, WARRANTIES AND COVENANTS

4

Section 5.1

Financial Institution’s Representations and Warranties

4

EX-10.7·8-K·CIK 1844964·ACC 0000929638-26-002382·Filed Jun 29, 2026, 16:47 ET